Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoyan Granules refers to a group of traditional Chinese medicine (TCM) herbal formulations used for their anti-inflammatory and heat-clearing properties. The specific composition can vary by formulation and manufacturer. For example, Jianwei Xiaoyan Granule (JWXYG) is widely used in China for the treatment of chronic atrophic gastritis and contains multiple herbal components such as albiflorin, paeoniflorin, and lobetyolin[1]. Another variant is Pudilan Xiaoyan granules which include Herba Taraxaci (dandelion), Radix Isatidis (woad root), Indigofera species extracts, baicalin, among others[2]. Mechanistically, these formulations are believed to exert therapeutic effects primarily through inhibition of angiogenesis via regulation of the HIF-1α-VEGF pathway in gastric tissue[1], as well as general anti-inflammatory actions. Some variants are also studied or used for pediatric conditions such as hand-foot-mouth disease or mumps[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiaoyan Granules.